PTN (Palatin Technologies) Margin of Safety % (DCF Earnings Based): N/A (As of Jun. 27, 2026)


PTN Palatin Technologies Inc PTN
39 GF Score
Price $11.39
GF Value $42.84
Valuation Possible Value Trap
! 5 Warning Signs
View Full Analysis

What is Palatin Technologies Margin of Safety % (DCF Earnings Based)?

Margin of Safety % (DCF Earnings Based) = (Intrinsic Value: DCF (Earnings Based) - Current Price) / Intrinsic Value: DCF (Earnings Based).

Note: Discounted Earnings model is only suitable for predictable companies (Business Predictability Rank higher than 1-Star). If the company's Predictability Rank is 1-Star or Not Rated, result may not be accurate due to the low predictability of business and the data will not be stored into our database.

Palatin Technologies's Predictability Rank is 1-Star. Thus, the DCF related results in the screener and portfolio will appear as zero and Margin of Safety % (DCF Earnings Based) is not calculated.

PTN vs CLRB, PLUR, VTGN: Margin of Safety % (DCF Earnings Based) Comparison

For the Biotechnology subindustry, Palatin Technologies's Margin of Safety % (DCF Earnings Based), along with its competitors' market caps and Margin of Safety % (DCF Earnings Based) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Palatin Technologies Margin of Safety % (DCF Earnings Based) vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Palatin Technologies's Margin of Safety % (DCF Earnings Based) distribution charts can be found below:

* The bar in red indicates where Palatin Technologies's Margin of Safety % (DCF Earnings Based) falls into.


PTN
39GF Score
Palatin Technologies Inc PTN
Margin of Safety % (DCF Earnings Based) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Palatin Technologies (PTN) Overvalued in 2026?

Based on GuruFocus' analysis, Palatin Technologies stock appears to be undervalued. The current stock price of $11.39 is trading 73.4% below its estimated GF Value™ of $42.84. GuruFocus considers Palatin Technologies to be Possible Value Trap.

Key valuation signals for PTN:

  • Margin of Safety % (DCF Earnings Based): N/A
  • GF Value™: $42.84 vs. price of $11.39 (73.4% below fair value)
  • GF Score™: 39/100 with 5 warning signs

No single metric tells the full story. See the PTN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Palatin Technologies Business Description

Other Exchanges 0KF3:UK
Address 103 Carnegie Center Drive, Suite 300, Princeton, NJ, USA, 08852
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system. The product candidates are targeted, receptor-specific therapeutics for the treatment of diseases with unmet medical needs and commercial potential. The Company's business is in one operating segment: life science.
39GF Score

Get the complete analysis for PTN

Margin of Safety % (DCF Earnings Based) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$11.39
Price
$42.84
GF Value